RE: 6100029 Oct 2018 12:20
Agreed rightback...but at this price, for me, it's a buy. The SP bears no resemblance to the valuations of Val's 101 to 401 drug line progress to date. I'm not waiting for a recovery of 1 or 2p before buying as these trades are bringing my average right down. It's my risk but having reviewed the information supplied todate, and with continued patience, I see increasing potential for a good recovery and, who knows, a profit. We will see. Best wishes. Freddie